Zhejiang Jiaoke: the amount of newly signed orders in the first quarter was 9.488 billion yuan, and the order stock was sufficient

Overview of China's Sanitation Self-Driving Market

This article introduces the market dynamics and trends of China's sanitation self-driving market. Specifically, the article presents the driving forces, application scenarios, business models, multiple players in the competitive landscape, and challenges. Also, the article brings you unique insights from executives and industry experts in industry-leading and fast-growing companies regarding technological know-how and business modes in the field.

Pre-clinical CRO ZHSK Lab Nets Over CNY 100 Mn in Series B

ZSHK, a pre-clinical Contract Research Organization (“Preclinical CRO”), raised funds from AZ-CICC and its existing investor Jishi Capital to enhance international deployment and key resources construction

Biotech Primelink Nets Over CNY 100 Mn

As a new star in the antibody-drug conjugate (“ADC”) industry, Primelink plans to build a more flexible ADC technology platform.

Fully Native Human mAb Drug Developer Trinomab Raises CNY 750 Mn in Pre-IPO Round

Despite increasing competition, the prospect of the monoclonal antibody drug market in China remains promising.

CTTQ, Ampsourcebio Ink Agreement on Cure for NASH, T2DM

There are more than 95 plus major players and more than 90 plus nonalcoholic steatohepatitis (NASH) pipeline therapies, but none of them has been approved for marketing. Who would survive the competition in the blue-ocean market for NASH?